This association of VRK2 expression to a better prognosis in malignant astrocytomas is likely to be associated to the roles that VRK2 plays in the modulation of mitogenic, stress or apoptosis signaling [29-32]. The gene discussed is VRK2; the disease is astrocytoma (excluding glioblastoma).